The novel coronavirus SARS-CoV-2 that causes COVID-19 and first identified in the Wuhan region of China [1] is an enveloped positive sense RNA virus of the family Coronaviridae and genus Betacoronavirus ([2].
In view of the potential application of IFITM proteinsâ€™ induction to target SARS-CoV-2 infection that causes COVID-19, this article layout insights into the known antiviral mechanisms and therapeutic agents related to IFITM.